Estrogen receptor-positive breast cancer

There are 52 papers on estrogen receptor-positive breast cancer in aging research: 1 trial and 29 observational studies in people, 1 in animals, 19 reviews.

Disease

52 papers study it5 more mention it17 findings

4 new papers in 30 daysSee all 57 papers on estrogen receptor-positive breast cancer

“Receptor-specific analyses revealed positive associations with estrogen receptor-positive breast cancer (total and premenopausal).”
Dietary exposure to acrylamide and breast cancer risk: results from the NutriNet-Santé cohortThe American journal of clinical nutrition2022doi:10.1093/ajcn/nqac167
  • Human trial1
  • Humans29
  • Animals1
  • In silico2

Interventions

1

Metformin

no changein humans1

1 study
  1. Metformin was not clearly linked with estrogen receptor-positive breast cancer in humans (women with diabetes, subset with receptor data available).

    Humanswomen with diabetes, subset with receptor data availablefemales

More on Metformin

Upstream

3

C-reactive protein

no changein humans1RR 1.03

1 study
  1. C-reactive protein was not clearly linked with estrogen receptor-positive breast cancer in humans (RR 1.03 (0.95, 1.11)).

    Humansbloodfemalesn = 1,223

More on C-reactive protein

Sleep disorders

no changein humans1OR 0.98

1 study
  1. Sleep disorders were not clearly linked with estrogen receptor-positive breast cancer in humans (ER+ breast cancer) (OR 0.98, 95% CI 0.94-1.02, P = 0.304).

    HumansER+ breast cancer

More on Sleep disorders

Age at menopause

mediatesin humans1−4.8% mediation proportion

1 study
  1. Age at menopause is linked with estrogen receptor-positive breast cancer in humans (mediation of the effect of polycystic ovary syndrome) (-4.82% mediation proportion).

    Humansmediation of the effect of polycystic ovary syndrome

Associations

13

TNF-alpha

no changein humans1RR 1.27

1 study
  1. TNF-alpha is associated with estrogen receptor-positive breast cancer in humans (RR: 1.27, 95% CI: 0.96, 1.68).

    Humansbloodfemalesn = 1,223

More on TNF-alpha

Adiponectin

no changein humans1RR 1.1

1 study
  1. Adiponectin is associated with estrogen receptor-positive breast cancer in humans (RR: 1.10, 95% CI: 0.90, 1.34).

    Humansbloodfemalesn = 1,223

More on Adiponectin

IL-10

upin humans1RR 1.14

1 study
  1. IL-10 is linked with a higher risk of estrogen receptor-positive breast cancer in humans (RR: 1.14, 95% CI: 1.01, 1.29).

    Humansbloodfemalesn = 1,223

More on IL-10

Leptin

upin humans1RR 1.13

1 study
  1. Leptin is linked with a higher risk of estrogen receptor-positive breast cancer in humans (RR: 1.13, 95% CI: 1.03, 1.25).

    Humansbloodfemalesn = 1,223

More on Leptin

Estrogen receptor-positive breast cancer polygenic risk score

upin humans1

1 study
  1. Estrogen receptor-positive breast cancer polygenic risk score predicts estrogen receptor-positive breast cancer in humans (African ancestry) (AUC 0.621; external validation AUC 0.640).

    HumansAfrican ancestryfemales

More on Estrogen receptor-positive breast cancer polygenic risk score

Reproductive senescence

upin mice1

1 study
  1. Reproductive senescence raises the risk of estrogen receptor-positive breast cancer in mice.

    Animals

ESR1

upin mice1

1 study
  1. ESR1 raises the risk of estrogen receptor-positive breast cancer in mice (overexpression induced just before or with reproductive senescence).

    Animalsoverexpression induced just before or with reproductive senescencemammary gland

More on ESR1

Acrylamide

upin humans1

1 study
  1. Acrylamide is associated with estrogen receptor-positive breast cancer in humans (Total and premenopausal analyses).

    HumansTotal and premenopausal analysesfemales

More on Acrylamide

Age at menopause

upin humans1

1 study
  1. Age at menopause is associated with estrogen receptor-positive breast cancer in humans (also associated with ER- BC).

    Humansalso associated with ER- BCfemales

More on Age at menopause

Physical activity

downin humans1

1 study
  1. Physical activity lowers the risk of estrogen receptor-positive breast cancer in humans (postmenopausal women).

    Reviewpostmenopausal womenfemales

More on Physical activity

All 13

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 2Feb 2026: 3Mar 2026: 2Apr 2026: 0May 2026: 1Jun 2026: 2Jul 2026: 1Aug 2026: 0Sep 2026: 3Oct 2026: 3Nov 2026: 320 papers in 12 months

See all 57 papers on estrogen receptor-positive breast cancer